Fig. 4From: The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey modelMHCSZ-123 inhibited ristocetin-induced platelet aggregation in a dose-dependent manner (3.5, 5, and 8Â mg/mL of MHCSZ-123). Platelet aggregation was induced by ristocetin (1.25Â mg/mL) under constant stirring conditionsBack to article page